小白菜
Lv21
120 积分
2025-01-03 加入
-
Structural insight into selectivity of amylin and calcitonin receptor agonists
7天前
已完结
-
Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial
10天前
已关闭
-
Design and Development of a New Glucagon-Like Peptide-1 Receptor Agonist to Obtain High Oral Bioavailability
19天前
已完结
-
Long-Acting, Longer-Acting, and Ultralong-Acting Antiobesity Peptides
1个月前
已完结
-
SNAC for Enhanced Oral Bioavailability: An Updated Review
1个月前
已完结
-
Prohormone cleavage prediction uncovers a non-incretin anti-obesity peptide
3个月前
已完结
-
Proline Analogues in Drug Design: Current Trends and Future Prospects
4个月前
已完结
-
Proline Analogues
4个月前
已完结
-
Strategic re-engineering of antibiotics
5个月前
已完结